Bio-Rad Laboratories, Inc. Stock NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 298.50 USD | +1.75% |
|
+0.68% | -3.93% |
| 07-01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 06-03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 7.94B 6.94B 6.4B 5.91B 11.22B 757B 11.41B 76.51B 30.04B 373B 29.8B 29.15B 1,282B | P/E 2026 * |
35.6x | P/E 2027 * | 34.8x |
|---|---|---|---|---|---|
| Enterprise Value | 7.19B 6.29B 5.8B 5.36B 10.16B 685B 10.33B 69.29B 27.21B 338B 26.99B 26.4B 1,161B | EV / Sales 2026 * |
2.8x | EV / Sales 2027 * | 2.65x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +1.75% | ||
| 1 week | +0.68% | ||
| Current month | +0.68% | ||
| 1 month | -1.86% | ||
| 3 months | +7.76% | ||
| 6 months | -3.93% | ||
| Current year | -3.93% |
| 1 week | 293.37 |  | 298.5 |
| 1 month | 289.23 | | 298.5 |
| Current year | 244.54 | | 312.75 |
| 1 year | 244.54 | | 321.12 |
| 3 years | 0 | | 387.55 |
| 5 years | 0 | | 818.6 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.75% | +0.68% | - | - | 7.94B | |
| -0.50% | -1.54% | -28.85% | -12.62% | 164B | |
| +1.80% | +0.82% | -6.73% | -3.92% | 107B | |
| +0.32% | +2.34% | +2.79% | +57.04% | 59.04B | |
| +0.79% | -3.68% | +39.99% | +54.50% | 51.72B | |
| +0.72% | -3.88% | -13.66% | -41.41% | 41.87B | |
| +0.47% | -4.98% | - | - | 34.7B | |
| +2.66% | +5.21% | -10.09% | -42.88% | 28.93B | |
| -1.10% | -3.29% | +55.70% | -5.76% | 24.99B | |
| 0.00% | -1.01% | -5.28% | -3.57% | 21.05B | |
| Average | +0.69% | -1.03% | +4.23% | +0.17% | 59.25B | |
| Weighted average by Cap. | +0.52% | -0.93% | -5.60% | +1.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.25B 2.07B 1.91B 3.63B 245B 3.69B 24.75B 9.72B 121B 9.64B 9.43B 415B | 2.63B 2.3B 2.13B 1.96B 3.73B 251B 3.79B 25.4B 9.97B 124B 9.89B 9.68B 426B |
| Net income | 225M 197M 181M 168M 318M 21.44B 323M 2.17B 851M 10.56B 844M 826M 36.32B | 230M 201M 185M 171M 325M 21.91B 330M 2.21B 870M 10.79B 863M 844M 37.1B |
| Net Debt | -749M -655M -604M -558M -1.06B -71.44B -1.08B -7.22B -2.84B -35.19B -2.81B -2.75B -121B | -965M -844M -779M -719M -1.37B -92.08B -1.39B -9.31B -3.65B -45.36B -3.62B -3.55B -156B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | $298.50 | +1.75% | 57 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
